D.A. Davidson & CO. Buys 144,832 Shares of UiPath, Inc. $PATH

D.A. Davidson & CO. increased its stake in shares of UiPath, Inc. (NYSE:PATH) by 23.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 752,448 shares of the company’s stock after acquiring an additional 144,832 shares during the period. D.A. Davidson & CO.’s holdings in UiPath were worth $10,068,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Inspire Investing LLC bought a new position in UiPath during the second quarter worth $891,000. AlphaQuest LLC grew its position in UiPath by 863.9% in the 2nd quarter. AlphaQuest LLC now owns 42,847 shares of the company’s stock worth $548,000 after purchasing an additional 38,402 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in shares of UiPath by 7.3% during the 2nd quarter. Russell Investments Group Ltd. now owns 1,445,644 shares of the company’s stock worth $18,448,000 after purchasing an additional 98,058 shares during the period. Pallas Capital Advisors LLC raised its position in shares of UiPath by 24.8% during the second quarter. Pallas Capital Advisors LLC now owns 105,834 shares of the company’s stock valued at $1,355,000 after buying an additional 21,058 shares during the last quarter. Finally, CWM LLC lifted its stake in shares of UiPath by 96.2% in the second quarter. CWM LLC now owns 312,073 shares of the company’s stock valued at $3,995,000 after buying an additional 152,988 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UiPath

In related news, CEO Daniel Dines sold 122,734 shares of the stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $17.06, for a total transaction of $2,093,842.04. Following the sale, the chief executive officer directly owned 368,202 shares in the company, valued at $6,281,526.12. This represents a 25.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ashim Gupta sold 240,874 shares of the firm’s stock in a transaction on Thursday, October 9th. The shares were sold at an average price of $17.28, for a total value of $4,162,302.72. Following the sale, the chief financial officer directly owned 696,117 shares of the company’s stock, valued at $12,028,901.76. This represents a 25.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,821,970 shares of company stock worth $30,448,280 over the last three months. 23.19% of the stock is owned by company insiders.

UiPath Stock Performance

PATH opened at $16.02 on Tuesday. The firm has a market cap of $8.57 billion, a price-to-earnings ratio of 38.15, a PEG ratio of 4.80 and a beta of 1.08. The firm’s 50-day simple moving average is $15.56 and its 200-day simple moving average is $13.69. UiPath, Inc. has a twelve month low of $9.38 and a twelve month high of $19.84.

UiPath (NYSE:PATH) last released its quarterly earnings results on Wednesday, December 3rd. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. The firm had revenue of $411.11 million for the quarter, compared to analyst estimates of $392.46 million. UiPath had a net margin of 14.79% and a return on equity of 3.73%. The company’s revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.11 earnings per share. As a group, sell-side analysts anticipate that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Weiss Ratings restated a “hold (c)” rating on shares of UiPath in a research note on Monday, December 29th. Evercore ISI boosted their price objective on UiPath from $15.00 to $17.00 and gave the company an “in-line” rating in a research report on Thursday, December 4th. Truist Financial set a $17.00 target price on UiPath in a research note on Thursday, December 4th. Mizuho raised their target price on UiPath from $14.00 to $15.00 and gave the stock a “neutral” rating in a research report on Thursday, December 4th. Finally, BMO Capital Markets boosted their price target on shares of UiPath from $13.00 to $17.00 and gave the company a “market perform” rating in a report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, UiPath presently has a consensus rating of “Hold” and a consensus target price of $15.85.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.